Calculated panel reactive antibody predicts outcomes on the heart transplant waiting list
from The Journal of Heart and Lung Transplantation
Sensitized heart transplant candidates spend more time and have higher mortality on the waiting list. Although the calculated panel-reactive antibody (CPRA) value is used to assign allocation priority to kidney transplant candidates in the United States, the relationship between CPRA and outcomes on the heart transplant waiting list is unknown.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063